A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression. / Rothe, Christian; Lund, Jørgen; Jenstrup, Morten Troels; Steen-Hansen, Christian; Lundstrøm, Lars Hyldborg; Andreasen, Asger Mølgaard; Lange, Kai Henrik Wiborg.

I: BMC Anesthesiology, Bind 20, Nr. 1, 33, 31.01.2020.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Rothe, C, Lund, J, Jenstrup, MT, Steen-Hansen, C, Lundstrøm, LH, Andreasen, AM & Lange, KHW 2020, 'A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression', BMC Anesthesiology, bind 20, nr. 1, 33. https://doi.org/10.1186/s12871-020-0952-y

APA

Rothe, C., Lund, J., Jenstrup, M. T., Steen-Hansen, C., Lundstrøm, L. H., Andreasen, A. M., & Lange, K. H. W. (2020). A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression. BMC Anesthesiology, 20(1), [33]. https://doi.org/10.1186/s12871-020-0952-y

Vancouver

Rothe C, Lund J, Jenstrup MT, Steen-Hansen C, Lundstrøm LH, Andreasen AM o.a. A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression. BMC Anesthesiology. 2020 jan. 31;20(1). 33. https://doi.org/10.1186/s12871-020-0952-y

Author

Rothe, Christian ; Lund, Jørgen ; Jenstrup, Morten Troels ; Steen-Hansen, Christian ; Lundstrøm, Lars Hyldborg ; Andreasen, Asger Mølgaard ; Lange, Kai Henrik Wiborg. / A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression. I: BMC Anesthesiology. 2020 ; Bind 20, Nr. 1.

Bibtex

@article{2ccd158077434ee7ab87ccf92a7e5954,
title = "A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression",
abstract = "BACKGROUND: The sensory innervation of the shoulder is complex and there are variations in the branching patterns of the sensory fibres. Articular branches from the axillary nerve to the subacromial bursa are described in more than 50% of investigated shoulders but the isolated contribution of sensory input from the axillary nerve has never been investigated clinically. We hypothesized that a selective block of the axillary nerve would reduce morphine consumption and pain after arthroscopic subacromial decompression.METHODS: We included 60 patients in a randomized, blinded, placebo-controlled study. Patients were randomized to a preoperative selective ultrasound-guided axillary nerve block with 20 mL ropivacaine (7.5 mg/mL) or 20 mL saline. Primary outcome was intravenous morphine consumption 0-4 h postoperatively. Secondary outcome was postoperative pain evaluated by a visual analogue scale (VAS) score (0-100).RESULTS: We analysed data from 50 patients and found no significant difference in 0-4 h postoperative morphine consumption between the two groups (ropivacaine 14 mg, placebo 18 mg (P = 0.12)). There was a reduction in postoperative pain: VAS 0-4 h (area under the curve) (ropivacaine 135, placebo 182 (P = 0.03)), VAS after 8 h (ropivacaine 9, placebo 20 (P = 0.01)) and VAS after 24 h (ropivacaine 7, placebo 18 (P = 0.04)). Eight out of 19 patients with a successful selective axillary nerve block needed an interscalene brachial plexus escape block.CONCLUSIONS: Selective block of the axillary nerve has some pain relieving effect, but in this setting the effect was unpredictable, variable and far from sufficient in a large proportion of the patients.TRIAL REGISTRATION: ClinicalTrials.gov (NCT01463865). Registered: November 1, 2011.",
author = "Christian Rothe and J{\o}rgen Lund and Jenstrup, {Morten Troels} and Christian Steen-Hansen and Lundstr{\o}m, {Lars Hyldborg} and Andreasen, {Asger M{\o}lgaard} and Lange, {Kai Henrik Wiborg}",
year = "2020",
month = jan,
day = "31",
doi = "10.1186/s12871-020-0952-y",
language = "English",
volume = "20",
journal = "BMC Anesthesiology",
issn = "1471-2253",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression

AU - Rothe, Christian

AU - Lund, Jørgen

AU - Jenstrup, Morten Troels

AU - Steen-Hansen, Christian

AU - Lundstrøm, Lars Hyldborg

AU - Andreasen, Asger Mølgaard

AU - Lange, Kai Henrik Wiborg

PY - 2020/1/31

Y1 - 2020/1/31

N2 - BACKGROUND: The sensory innervation of the shoulder is complex and there are variations in the branching patterns of the sensory fibres. Articular branches from the axillary nerve to the subacromial bursa are described in more than 50% of investigated shoulders but the isolated contribution of sensory input from the axillary nerve has never been investigated clinically. We hypothesized that a selective block of the axillary nerve would reduce morphine consumption and pain after arthroscopic subacromial decompression.METHODS: We included 60 patients in a randomized, blinded, placebo-controlled study. Patients were randomized to a preoperative selective ultrasound-guided axillary nerve block with 20 mL ropivacaine (7.5 mg/mL) or 20 mL saline. Primary outcome was intravenous morphine consumption 0-4 h postoperatively. Secondary outcome was postoperative pain evaluated by a visual analogue scale (VAS) score (0-100).RESULTS: We analysed data from 50 patients and found no significant difference in 0-4 h postoperative morphine consumption between the two groups (ropivacaine 14 mg, placebo 18 mg (P = 0.12)). There was a reduction in postoperative pain: VAS 0-4 h (area under the curve) (ropivacaine 135, placebo 182 (P = 0.03)), VAS after 8 h (ropivacaine 9, placebo 20 (P = 0.01)) and VAS after 24 h (ropivacaine 7, placebo 18 (P = 0.04)). Eight out of 19 patients with a successful selective axillary nerve block needed an interscalene brachial plexus escape block.CONCLUSIONS: Selective block of the axillary nerve has some pain relieving effect, but in this setting the effect was unpredictable, variable and far from sufficient in a large proportion of the patients.TRIAL REGISTRATION: ClinicalTrials.gov (NCT01463865). Registered: November 1, 2011.

AB - BACKGROUND: The sensory innervation of the shoulder is complex and there are variations in the branching patterns of the sensory fibres. Articular branches from the axillary nerve to the subacromial bursa are described in more than 50% of investigated shoulders but the isolated contribution of sensory input from the axillary nerve has never been investigated clinically. We hypothesized that a selective block of the axillary nerve would reduce morphine consumption and pain after arthroscopic subacromial decompression.METHODS: We included 60 patients in a randomized, blinded, placebo-controlled study. Patients were randomized to a preoperative selective ultrasound-guided axillary nerve block with 20 mL ropivacaine (7.5 mg/mL) or 20 mL saline. Primary outcome was intravenous morphine consumption 0-4 h postoperatively. Secondary outcome was postoperative pain evaluated by a visual analogue scale (VAS) score (0-100).RESULTS: We analysed data from 50 patients and found no significant difference in 0-4 h postoperative morphine consumption between the two groups (ropivacaine 14 mg, placebo 18 mg (P = 0.12)). There was a reduction in postoperative pain: VAS 0-4 h (area under the curve) (ropivacaine 135, placebo 182 (P = 0.03)), VAS after 8 h (ropivacaine 9, placebo 20 (P = 0.01)) and VAS after 24 h (ropivacaine 7, placebo 18 (P = 0.04)). Eight out of 19 patients with a successful selective axillary nerve block needed an interscalene brachial plexus escape block.CONCLUSIONS: Selective block of the axillary nerve has some pain relieving effect, but in this setting the effect was unpredictable, variable and far from sufficient in a large proportion of the patients.TRIAL REGISTRATION: ClinicalTrials.gov (NCT01463865). Registered: November 1, 2011.

U2 - 10.1186/s12871-020-0952-y

DO - 10.1186/s12871-020-0952-y

M3 - Journal article

C2 - 32005160

VL - 20

JO - BMC Anesthesiology

JF - BMC Anesthesiology

SN - 1471-2253

IS - 1

M1 - 33

ER -

ID: 250821987